Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Neuro-intervention uses minimally-invasive, catheter-based approaches to treat specific diseases of the blood vessels of the head, neck and spine. The most common conditions treated with the neuro-interventional devices include strokes, brain aneurysms, fistula, and vascular malformation formed in brain and spine, and carotid artery diseases. Neuro-interventional devices are also used in the treatment for various other health conditions such as transient ischemic attacks (TIA), cerebral artery stenosis, vertebral artery disease, compression fractures, and venous malformation of neck and head.

The global neuro-interventional devices market size is estimated to be valued at US$ 2358.1 million in 2020 and is expected to exhibit a CAGR of 4.0 % over the forecast period (2020-2027).

Figure 1. Global Neuro-interventional Devices Market Value (US$ Mn), 2016-2027

Neuro-interventional Devices  | Coherent Market Insights

The increasing incidence of various brain disorders such as brain aneurysm is expected to drive the growth of global neuro-interventional devices market over the forecast period. For instance, according to the Cerebral Aneurysms Fact Sheet, National Institute of Neurological Disorders and Stroke (NINDS) published on 2018, stated that around 30,000 people in the U.S. suffer from brain aneurysm rupture, annually.

request-sample

Neuro-interventional Devices Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 2358.1 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 4.0% 2027 Value Projection: US$ 3104.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy Devices, Embolic Protection Devices, Flow Diverters Devices , Intrasaccular Devices, Liquid Embolic Devices, Balloon Devices, Stent Retrievers.
  • By End User: Hospitals, Clinics.
  • By Technique: Neurothrombectomy Procedures, Cerebral Angiography, Stenting Coiling Procedures, Flow Disruption.
Companies covered:

Stryker Corporation, Penumbra Inc., Medtronic, Johnson & Johnson Private Limited, Imperative Care, Inc., Anaconda Biomed SL, Insera Therapeutics, Perflow Medical Ltd., Terumo Corporation, MicroPort, and Rapid Medical Ltd.

Growth Drivers:
  • Increasing prevalence of brain disorders such as brain aneurysm and traumatic brain injuries (TBI) globally
  • Key companies focusing on product launches and product approvals in the global neuro-interventional devices market
  • Rising incidence of ischemic strokes in individuals globally
Restraints & Challenges:
  • High cost of neuro-interventional devices

Global Neuro-interventional Devices Market – Impact of Coronavirus (Covid-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in over 55 million infected individuals worldwide as of November 2020.

Moreover, COVID-19 has also affected the neuro-interventional devices market in the following ways:

Nationwide lockdowns in several countries resulting from the coronavirus pandemic have negatively impacted development, production, and supply of interventional devices and affected growth of the healthcare businesses of various companies across the globe. These lockdowns have led to closure of industrial establishments except manufacturing of essential commodities and disruption in supply of products.

Thus, the COVID-19 pandemic has affected the economy in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) by its financial impact on firms and financial markets.

Figure 2. Global Neuro-interventional Devices Market Share (%), by Region, 2020

Neuro-interventional Devices  | Coherent Market Insights

Among regions, North America is expected to exhibit significant growth in the global neuro-interventional devices market, owing to key companies focusing on raising funds to expand their product portfolio in the market. For instance, in 2019, Imperative Care, Inc. announced that they have completed the initial closing of a series C financing of US$ 85 million to support the commercial launch of company’s medical devices, which include latest technological advances in neurovascular devices used to treat strokes.  

Key Players

Major players operating in the global neuro-interventional devices market include Stryker Corporation, Penumbra Inc., Medtronic, Johnson & Johnson Private Limited, Imperative Care, Inc., Anaconda Biomed SL, Insera Therapeutics, Perflow Medical Ltd., Terumo Corporation, MicroPort, and Rapid Medical Ltd.

The global neuro-interventional device market mainly include different products such as embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices , embolic protection devices, flow diverters devices, intrasaccular devices, liquid embolic devices, balloon devices, and stent retrievers, which are used for different intervention procedures. Interventional procedures follow different techniques such as neurothrombectomy procedures, cerebral angiography, stenting coiling procedures, and flow disruption. 

Market Dynamics

The global neuro-interventional device market is expected to exhibit significant growth over the forecast period due to key companies focusing on product launches and product approvals. For instance, in 2019, Insera Therapeutics, Inc, received Conformité Européenne (CE) Mark approval for its product, the CLEAR Aspiration System that is used for the treatment of acute pulmonary embolism.

Key features of the study:

  • This report studies the current scenario as well as the future potential for the global neuro-interventional device market. The market for neuro-interventional devices is segmented on basis of product type, end user, techniques, and region.
  • This report provides in-depth analysis of the global neuro-interventional device market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020 – 2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the global neuro-interventional device market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Key players operating in the global neuro-interventional devices market include Stryker Corporation, Penumbra Inc., Medtronic, Johnson & Johnson Private Limited, Imperative Care, Inc., Anaconda Biomed SL, Insera Therapeutics, Perflow Medical Ltd., Terumo Corporation, MicroPort, and Rapid Medical Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics.
  • The global neuro-interventional devices solutions market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts.
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the global neuro-interventional devices market

Detailed Segmentation:

  • Global Neuro-interventional Devices Market, By Product Type :
    • Embolic Coils
    • Carotid Stents
    • Intracranial Stents
    • Neurovascular Thrombectomy Devices
    • Embolic Protection Devices
    • Flow Diverters Devices
    • Intrasaccular Devices
    • Liquid Embolic Devices
    • Balloon Devices
    • Stent Retrievers  
  • Global Neuro-interventional Devices Market, By End User :
    • Hospitals
    • Clinics
  • Global Neuro-interventional Devices Market, By Technique :
    • Neurothrombectomy Procedures
    • Cerebral Angiography
    • Stenting Coiling Procedures
    • Flow Disruption
  • Global Neuro-interventional Devices Market, By Region:
    • North America
      • By Product Type :
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy Devices
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic Devices
        • Balloon Devices
        • Stent Retrievers  
      • By End User :
        • Hospitals
        • Clinics
      • By Technique:
        • Neurothrombectomy Procedures
        • Cerebral Angiography
        • Stenting Coiling Procedures
        • Flow Disruption
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type :
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy Devices
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic Devices
        • Balloon Devices
        • Stent Retrievers  
      • By End User :
        • Hospitals
        • Clinics
      • By Technique:
        • Neurothrombectomy Procedures
        • Cerebral Angiography
        • Stenting Coiling Procedures
        • Flow Disruption
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type :
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy Devices
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic Devices
        • Balloon Devices
        • Stent Retrievers  
      • By End User :
        • Hospitals
        • Clinics
      • By Technique:
        • Neurothrombectomy Procedures
        • Cerebral Angiography
        • Stenting Coiling Procedures
        • Flow Disruption
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type :
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy Devices
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic Devices
        • Balloon Devices  
        • Stent Retrievers  
      • By End User :
        • Hospitals
        • Clinics
      • By Technique:
        • Neurothrombectomy Procedures
        • Cerebral Angiography
        • Stenting Coiling Procedures
        • Flow Disruption
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type :
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic Devices
        • Balloon Devices
        • Stent Retrievers  
      • By End User :
        • Hospitals
        • Clinics
      • By Technique:
        • Neurothrombectomy Procedures
        • Cerebral Angiography
        • Stenting Coiling Procedures
        • Flow Disruption
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type :
        • Embolic Coils
        • Carotid Stents
        • Intracranial Stents
        • Neurovascular Thrombectomy Devices
        • Embolic Protection Devices
        • Flow Diverters Devices
        • Intrasaccular Devices
        • Liquid Embolic Devices
        • Balloon Devices
        • Stent Retrievers  
      • By End User :
        • Hospitals
        • Clinics
      • By Technique:
        • Neurothrombectomy Procedures
        • Cerebral Angiography
        • Stenting Coiling Procedures
        • Flow Disruption
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    •  Stryker Corporation*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Penumbra Inc.
    • Medtronic
    • Johnson & Johnson Private Limited
    • Imperative Care, Inc.
    • Anaconda Biomed SL
    • Insera Therapeutics
    • Perflow Medical Ltd.
    • Terumo Corporation
    • MicroPort
    • Rapid Medical Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By End User
      • Market Snapshot, By Technique
      • Market Snapshot, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Impact Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Recent Product Launch
    • Key Developments
    • Acquisition and Collaboration Scenario
    • PEST Analysis
    • PORTER’S Analysis
  4. Global Neuro-interventional Devices Market, Impact of COVID-19 Pandemic
    • COVID-19 Epidemiology
    • COVID-19 Impact
  5. Global Neuro-interventional Devices Market, By Product Type, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017-2027
      • Segment Trends
        • Embolic Coils
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Carotid Stents
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Intracranial Stents
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Neurovascular Thrombectomy Devices
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Embolic Protection Devices
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Flow Diverters Devices
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Intrasaccular Devices
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Liquid Embolic Devices
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Balloon Devices
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Stent Retrievers
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)  
  6. Global Neuro-interventional Devices Market, By End User, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Hospitals
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Clinics
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  7. Global Neuro-interventional Devices Market, By Technique, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Neurothrombectomy Procedures
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Cerebral Angiography
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Stenting Coiling Procedures
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Flow Disruption
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  8. Global Neuro-interventional Devices Market, By Region, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Technique, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Technique, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Technique, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Germany
        • U.K.
        • France       
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Technique, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Technique, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Technique, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016–2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
      • Stryker Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Penumbra Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson Private Limited
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Imperative Care, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Anaconda Biomed SL
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Insera Therapeutics
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Perflow Medical Ltd.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • MicroPort
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Rapid Medical Ltd.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 33 market data tables and 32 figures on "Neuro-interventional Devices Market– Global forecast to 2027”.

Frequently Asked Questions

The global neuro-interventional devices market size is estimated to be valued at US$ 2358.1 million in 2020 and is expected to exhibit a CAGR of 4.0 % between 2020 and 2027.
The increasing prevalence of brain disorders such as brain aneurysm and traumatic brain injuries (TBI) globally, key companies focusing on product launches and product approvals in the global neuro-interventional devices market, and rising incidence of ischemic strokes in individuals globally are driving growth of the global neuro-interventional device market.
Neurovascular thrombectomy devices segment is estimated to hold major market share in 2020, owing to rising prevalence of acute ischemic stroke in individuals globally.
Neurothrombectomy procedure is estimated to hold major market share in 2020, owing to less minimally invasive procedure and also less pain experienced by patients after neuro-interventional surgery.
North America region is estimate to account for largest revenue share in 2020 in the global neuro-interventional device market during the forecast period.
High cost of neuro-interventional devices is a key factor that is expected to hamper growth of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner